Silvana Cabrera Puentes

Silvana Cabrera Puentes

Auto-generated profile, based on publicly available information

Silvana Cabrera Puentes

Hospital de Alta Especialidad Bicentenario de la Independencia Universidad Autonoma de Guadalajara Servicios Médicos Integrales Populares Fundación Universitaria Sanitas Pontificia Universidad Javeriana Pontificia Universidad Católica del Ecuador Instituto de Educación Capacitación y Certificación de México

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2025 in IECCMEXICO
Verified
Journal Article
Closed access
JCJorge Luis Acosta Cortez
Jorge Luis Acosta Cortez
JMJuan Diego Paloma Meza
Juan Diego Paloma Meza
ARArizbeth Miroslava Pinales Ramírez
Arizbeth Miroslava Pinales Ramírez
SPSilvana Cabrera Puentes
Silvana Cabrera Puentes
RGRicardo Daniel Corona González
Ricardo Daniel Corona González
IHIngrid Monserrat Jaimes Hernández
Ingrid Monserrat Jaimes Hernández
The global shortage of essential medicines has emerged as a persistent and multifaceted public health challenge, driven by structural, economic, and regulatory vulnerabilities within the international pharmaceutical supply chain. This review analyzed twenty scientific and institutional sources from North America, Europe, and Latin America—specifically Mexico, Colombia, and Ecuador—to identify the primary determinants, patterns, and responses associated with this phenomenon. Results show a steady increase in global shortages between 2014 and 2025, largely due to the concentration of active pharmaceutical ingredient (API) production in a few countries, low-profit margins discouraging redundancy among generic manufacturers, and fragmented regulatory frameworks that delay mitigation. High-income regions such as the United States and the European Union have developed preventive, data-driven strategies, including early-warning systems, quality risk management, and Shortage Prevention Plans (SPPs). In contrast, Latin America remains dependent on imports, limited domestic production capacity, and reactive procurement mechanisms. The proposed eight-pillar framework integrates governance, manufacturing diversification, resilient procurement, regulatory agility, data transparency, clinical stewardship, and regional cooperation as interdependent dimensions for building pharmaceutical resilience. These findings highlight that shortages are not isolated technical issues but manifestations of systemic governance failures that threaten equity, continuity of care, and trust in health institutions. Ensuring the continuous availability of essential medicines demands a paradigm shift from reactive management to preventive, coordinated, and ethically grounded governance aligned with Sustainable Development Goal 3. Future research should focus on quantitative modeling of supply-chain vulnerabilities, cost-effectiveness analysis of resilience investments, and region-specific studies to design adaptive policies in Latin America and other low- and middle-income regions.

8 October 2025 in International Science Journal
Verified
Journal Article
Closed access
CVCarolina Paola Ortiz Valdés
Carolina Paola Ortiz Valdés
XAXóchitl Monteon Aspeitia
Xóchitl Monteon Aspeitia
HMHillary Yahiry Mejía Montiel
Hillary Yahiry Mejía Montiel
SPSilvana Cabrera Puentes
Silvana Cabrera Puentes
CHClaudia Zamaly Ferreira Hernández
Claudia Zamaly Ferreira Hernández
ACAndrea Cristina Naranjo Calvachi
Andrea Cristina Naranjo Calvachi
Inflammatory skin diseases are increasingly understood through the lens of the cutaneous microbiome, a dynamic ecosystem whose interactions with the host shape immune responses, barrier integrity, and clinical disease expression. This review synthesizes evidence from two decades of research to examine how microbial composition, functional dysbiosis, and host–microbe crosstalk contribute to the pathophysiology of atopic dermatitis, psoriasis, acne, rosacea, and Malassezia-associated dermatoses. The findings demonstrate that innate immune mechanisms—particularly barrier components, antimicrobial peptides, and pattern recognition receptors—form the primary interface between the microbiome and the host, while disease-specific adaptive pathways (Th2 in atopic dermatitis, Th17 in psoriasis) define distinct inflammatory phenotypes. Temporal trends reveal a rapid expansion of microbiome research beginning in the late 2010s, driven by advances in sequencing and molecular immunology, while thematic analysis highlights an imbalance between mechanistic studies and the still limited development of microbiome-based therapies. The review also identifies a critical gap concerning the underrepresentation of diverse populations, especially in regions such as Mexico, Colombia, and Ecuador, where environmental and cultural factors significantly influence microbial ecology. Collectively, the evidence underscores the microbiome’s central role in shaping cutaneous inflammation and emphasizes the need for geographically inclusive research and translational innovation to support future dermatologic practice.

3 November 2025 in IECCMEXICO
Verified
Journal Article
Closed access
DMDulce Rocío Flores Montiel
Dulce Rocío Flores Montiel
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
TSTiffany Ivanna Guerrero Solórzano
Tiffany Ivanna Guerrero Solórzano
SPSilvana Cabrera Puentes
Silvana Cabrera Puentes
EEErwin Giovanny Mercado Estrada
Erwin Giovanny Mercado Estrada
ANAlexa Fernanda Uriostegui Navarro
Alexa Fernanda Uriostegui Navarro
Childhood obesity has emerged as a critical global health challenge with growing prevalence across Latin America, particularly in Mexico, Colombia, and Ecuador. This review synthesizes current international evidence on the biological, behavioral, and policy determinants of obesity and evaluates preventive strategies within clinical, educational, and governmental frameworks. Data reveal that fewer than one in five children meet physical activity guidelines, while sugar-sweetened beverage (SSB) consumption and inadequate sleep remain pervasive contributors to metabolic risk. Family-based behavioral programs with at least 26 contact hours and multicomponent school interventions—including daily physical activity, canteen reform, and sleep literacy—produce the most consistent reductions in BMI z-scores and metabolic markers. Fiscal and regulatory measures, such as SSB taxation and front-of-package labeling, complement these interventions by reshaping food environments and reducing health inequities when properly enforced. The integrated Clinic–School–Home–Policy framework proposed in this study offers a sustainable model that aligns individual behavior with supportive environments and governance mechanisms. Long-term success depends on cross-sector collaboration, continuous evaluation, and social participation to ensure equitable access to healthy food, safe physical activity, and sleep-promoting routines. By transforming policy and practice into a unified prevention ecosystem, Latin American nations can reverse current trends and safeguard the health and well-being of the next generation.

12 March 2025 in Revista Mexicana de Urología
Verified
Journal Article
Closed access
Orión Erenhú Rodríguez GonzalezOrión Erenhú Rodríguez Gonzalez
Orión Erenhú Rodríguez Gonzalez
CFChristian Aarón Martínez Flores
Christian Aarón Martínez Flores
UBUriel Castañeda Bonilla
Uriel Castañeda Bonilla
BCBrenda Suaste Carmona
Brenda Suaste Carmona
EFEduardo Antonio Gandara Flores
Eduardo Antonio Gandara Flores
KSKaren Montserrat Reyes Sanchez
Karen Montserrat Reyes Sanchez
Description: Paruresis, also known as Shy Bladder Syndrome or situational inability to urinate, is defined as the inability to initiate or maintain urination in the presence of others due to fear of scrutiny. The varying degrees of severity and the fact that it is not a life-threatening condition lead to it being underdiagnosed and poorly studied, causing significant interpersonal, social deterioration and impacting the patient's quality of life. Relevance: There is little research on this condition, as it presents a wide variability of symptoms. Given its likelihood of initial diagnosis in urological consultations, a narrative review was undertaken to characterize the current state of the art. Conclusions: Paruresis is a complex medical disorder. The lack of awareness among various specialties contributes to poor treatment outcomes. Only education, research, and a multidisciplinary approach will allow progress in understanding this condition.